Filing Details

Accession Number:
0001127602-24-009365
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-03-11 16:06:05
Reporting Period:
2024-03-07
Accepted Time:
2024-03-11 16:06:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
352915 Universal Health Services Inc UHS Services-General Medical & Surgical Hospitals, Nec (8062) 232077891
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1181033 Steve Filton Universal Health Services, Inc.
367 South Gulph Road
King Of Prussia PA 19406
Executive Vice President & Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class B Common Stock Acquisiton 2024-03-07 70,000 $134.02 163,800 No 4 M Direct
Class B Common Stock Disposition 2024-03-07 60,015 $178.27 103,785 No 4 F Direct
Class B Common Stock Disposition 2024-03-08 35,000 $176.82 68,785 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class B Common Stock Option To Purchase Class B Common Stock Disposition 2024-03-07 70,000 $0.00 70,000 $134.02
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2024-03-19 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Class B Common Stock 80,500 Indirect The Betsy H. Filton 2020 Irrevocable Trust
Class B Common Stock 80,500 Indirect The Steve G. Filton 2020 Irrevocable Trust
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $176.54 to $177.465, inclusive. The reporting person undertakes to provide Universal Health Services, Inc. (the "Company"), any stockholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote 1.
  2. Option vested ratably on each of 3/20/2020, 3/20/2021, 3/20/2022, and 3/20/2023.